Behandling med filgrastim alene forhindrer ikke trombocytopeni og anæmi fremkaldt af myelosuppresiv kemoterapi.
Treatment with filgrastim alone does not preclude thrombocytopenia and anaemia due to myelosuppressive chemotherapy.